Subscribe
shutterstock_436917634_eqroy
EQroy / Shutterstock.com
8 October 2020Big PharmaMuireann Bolger

South Africa, India urge WTO to waive IP for COVID-19 treatments

South Africa and India have asked the World Trade Organization (WTO) to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.
Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.
Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.

More on this story

Americas
BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.
Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool